A novel combination of levofloxacin and ibuprofen shows enhanced efficacy in treating bacterial keratitis, outperforming monotherapy in a preclinical study.
Background
Bacterial keratitis is a significant cause of vision loss, exacerbated by rising antimicrobial resistance. The exploration of combination therapies that integrate anti-infective and anti-inflammatory mechanisms may provide new avenues for management.
Data Highlights
Treatment Group
Outcome
Levofloxacin alone
Moderate efficacy
Ibuprofen alone
Limited efficacy
Combination therapy
Consistently superior outcomes across microbiological, molecular, and histological endpoints
Key Findings
The combination of levofloxacin 0.5% and ibuprofen 0.3% demonstrated a synergistic effect, reducing the MIC of levofloxacin by up to eightfold.